University Hospital of North Norway
unn.noLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
148
Active
24
Phase 3
5
Total enrollment
43,660
Pipeline matrix
Showing 9 of 9 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| PRP | — | — | — | — | — | 1 | |
| ADSTEM Inj. | — | — | — | — | — | 1 | |
| Injection | — | — | — | — | — | 1 | |
| Saline | — | — | — | — | — | 1 | |
| Fecal microbiota transplantation | — | — | — | — | — | 1 | |
| Ketamine Hydrochloride | — | — | — | — | — | 1 | |
| Midazolam Hydrochloride | — | — | — | — | — | 1 | |
| Biological: Preprocessed thawed donor FMT | — | — | — | — | — | 1 | |
| Para Aminohippurate | — | — | — | — | — | 1 |
Next readouts
- 2023-09-01
- 2026-10
- 2026-12-31
- 2027-07-01
- 2027-12
Top conditions
- Stroke5
- Irritable Bowel Syndrome3
- Breast Cancer3
- Quality of Life3
- Stroke, Acute3
- Heart Failure2
- Depression2
- Cognitive Impairment2
Frequently asked questions about University Hospital of North Norway
- How many clinical trials does University Hospital of North Norway have on ClinicalTrials.gov?
- University Hospital of North Norway is listed as the lead sponsor on 148 clinical trials in ClinicalTrials.gov, 24 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Hospital of North Norway's trials are in Phase 3?
- 5 of University Hospital of North Norway's trials are in Phase 3, spread across 9 active drug programs.
- What therapeutic areas does University Hospital of North Norway focus on?
- University Hospital of North Norway's most-studied conditions on ClinicalTrials.gov are Stroke, Irritable Bowel Syndrome, Breast Cancer, Quality of Life, Stroke, Acute.
- When are University Hospital of North Norway's next clinical trial readouts?
- University Hospital of North Norway has 5 upcoming primary-completion readouts tracked here; the soonest is “Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome”, expected around 2023-09-01.